Member Info for TorquayFan

Thanks for that Burble - Scancell's 'Covidity' certainly ticks a lot of boxes - hopefully. News soon ?

Nice one WTP

Good post and fair enough AB - nicely put. It's a matter of comfort. At 22p as we were for so long, I was more 'comfortable' then, above my average, whilst I am now less comfortable now, below it at 12p. As for publicity, you are again in essence, quite correct in my view but I am among those myself who have thirsted for publicity - the reason being while we wait for data it would be nice , to feel more 'comfortable'.

I claim no great wisdom in this, it's simply human nature ! And AIMHO

Well done for trying Burble ! I'm sure you'll get it done at the next attempt. All your efforts are greatly appreciated here and that's for sure. Come on Scancell . . . .

Lozan returns ! He comments ". . . . to those who have shown *genuine* concern as to my welfare whilst I have *been somewhat indisposed*. It is appreciated . . "

Inan comments, "The Doom and Gloom show back on". . . . . Here we go !

Glad to see the old digger is OK

Re. Covid - 'they think it's all over' - not yet apparently. Also there are concerns about more serious symptoms from BA5 infections. Grim as it is to contemplate further harrowing pandemic times, there is obviously massive potential for a 'universal' vaccine.

Massive potential too for a vaccine with much wider coverage and longer lasting immunity . . . . .

Johnyw - Don't be deterred and I hope you will post again . . . . . IMO it's OK to take a guess at the date of the next RNS because a guess is what it is and no more than that. So 1st August it is ! We'll see ! I hope you are right . . .

Long experience with Scancell is that news can arrive, anytime. But unfortunately, never soon enough. ATB

Hi Cleaner - re. 'Scancell won't bring their ball to the table'. Maybe, we just don't know. For me, the trouble is with CEPI supporting other projects, what might turn up ? Time will tell blah blah. ATB

Violin re. CEPI that's long been a question . . . particularly as CEPI have been aware of 'Covidity' from it's early stages. We just don't know. Maybe strings hang from CEPI involvement from which, our BoD wish to remain free ?

It is frustrating as we wait, apparently interminably, for one of our brilliant projects to finally cross that line and give SCLP an event with some step change . . . . .

Burble great news for that Lady. Let's hope we hear about some Modi 1 triumphs before too long.

Flakey - that Sky piece is fascinating and good luck to the patient. Yes Prof. Ottensmeier in action. Experimental and engineered for that person - Transgene. Brilliant whatever.

Modi 1 next please !!!

Ruck - I guess that's it then. Over there the iPad posts without an underlining - iPads can access it but not laptops. I guess I'm not the only one NOT using an iPad which explains the odd rec for my 'conversion'. Thanks.

Ruck thanks for answering. LSE I get it but ADVFN 51266 doesn't work for me. 51267 does ! That's all.
Thanks.

WTP both links work OK. Thanks.
Please would you try the link in 51266 over there.
My theory is that links there NOT underlined and links here, not blue, don't work at all. ATB

For BioTech generally, a 'vicious sell-off' has run it's course' it says here - let's hope so !
Come on Scancell !!

"Hedge funds are hunting for bargains in the beaten-down biotechnology sector, betting that a vicious sell-off has run its course and that lower valuations will breathe life back into deal flow. A Nasdaq index of biotech stocks has tumbled almost a third from its all-time high last August, as hopes about the Covid-19 pandemic boosting the industry gave way to worries about frothy share prices. The sharp sell-off has, in turn, left many companies struggling to raise new funding.

However, some hedge fund managers now believe that prices have fallen too far relative to firms’ drug development prospects and their remaining cash levels. Those investors have started buying up stocks on the cheap, or launching portfolios to capitalise on the turmoil. “This is the worst correction [in the biotech sector] I have seen in my 22-year career”, said Michele Gesualdi, founder of London-based investment group Infinity Investment Partners. “We have never seen stress like this.” Gesualdi’s firm, which manages $1.5bn in assets, recently launched a new fund specifically to focus on opportunities in the life sciences sector. He added that the sector is, on all metrics, “as cheap as it has ever been”. "

https://www.ft.com/content/bfd7d96f-2af9-4614-b1eb-78949365de9a

Violin - 13/6 RNS FPD Modi 1, 15/6 RNS SCIB1 trial revamp, 23/6 RNS antibodies.

The news is coming thick and fast - why so impatient ? The SP IS disappointing of course but data, deal or a left field will soon fix that.

Amongst wise words in AB's 14.57 yesterday, "I believe a quiet wait is the best way of looking at this. One day we'll all get a (hopefully) happy surprise.:"

GLA

"So if upcoming vaccines are based on the original Omicron, called BA.1, there is a real possibility that by the time they are rolled out later this year, circulating Omicron strains will be different. “BA.1 is yesterday’s news,” says John Beigel, a physician-scientist at the US National Institute of Allergy and Infectious Diseases (NIAID) in Bethesda, Maryland, who is leading a trial of potential vaccine updates.

It is also possible — and some scientists say likely — that an entirely new variant will pop up from a distant part of the SARS-CoV-2 family tree. “My concern is that there’s this huge focus on Omicron, and the assumption that Omicron is what we will be dealing with in the future,” says Penny Moore, a virologist at the University of the Witwatersrand in Johannesburg, South Africa. “We have a strong track record of getting that wrong.”

As a result of such uncertainty, scientists say the next COVID-19 vaccines need to cast a wide net, ideally eliciting an immune response that can recognize variants past, present and future. “The broadest response is definitely what I want,” says Deming." https://www.nature.com/articles/d41586-022-01771-3?

LLass. Is that a 'keypad'? Is that a 'jetski'?

As for pottering around a lovely Coast - I get it ! I spent the last 2 weeks wandering around the Lizard, Kynance, Mullion, Cadgewith etc. etc. Looking down on those beautiful clear waters I can see it would be fine indeed to quietly potter around down there. In calm weather, a sea scooter, kayak or similar would be wonderful. One day maybe . . .

I see some trades going through - maybe some blue or red soon ?

Beautifully argued RW and pleasant as ever . . .

RW I've been gardening. But now I'm back, why didn't you answer the question at all? i.e. how well did the UK do in handling the Covid pandemic (?) instead of being so unpleasant, (true to type). BFN

Dalester with respect I quoted Brazil 3110 but there is also Argentina 2804, Peru 6900 and Columbia 2699 amongst the worst, all in the Southern Hemisphere at a quick look. . . . and yes Vitamin D is important but it can't possibly explain a 10x differential can it?

Ruck the statistics are longstanding now and it is very hard to believe they can be in error to the tune of 10x ? Try to answer why the UK recorded 10x DPM of other Nations with different policies as mentioned. BTW you are notorious for 'discussing to death' yourself and I haven't posted about this for at least 6 months.

So, how well did the UK do in handling the Covid pandemic ? Off to lunch. ATB

Morning all - just for the weekend . . .

As Boris basks in his latest glories of Partygate and Electoral dismissals and now looks forward to convincing a Parliamentary Committee that he is NOT a bare faced serial bender of the truth, let's have another look at last two years and (IMO), the UK's questionable handling of the Covid pandemic.

Leaving aside obviously barmy ideas about mass crowded events and shaking hands and sharing around the deadly virus for wider benefit (?), I ask the knee up apologists how they can now explain the following differentials in dpm rates still showing as the Stats mature :-

DPM in Brazil 3110, USA 3108, UK 2623, Russia 2607, Sweden 1864

DPM in Japan 248, New Zealand 282, Australia 371, Thailand 436

The 1st group here (except Sweden) are all run by odd to barmy/vicious characters

The 2nd group all embracing tight restrictions on international travel, lockdowns, mask wearing etc.

What conclusions ? All the old cobblers about cultures, ethnicity etc. cannot explain such differentials of this size, so let's put them aside shall we ?

The UK's terrible toll is despite the wonderful efforts of the Vaccine Task Force.

So, in truth, political positions aside, how well did the UK do in handling the Covid pandemic ?